Pancreatic cyst development: Insights from von Hippel-Lindau disease

Cilia

Volumn 2, Issue 1, 2013, Pages

  Van Asselt, Sophie J ^a   De Vries, Elisabeth GE ^a   Van Dullemen, Hendrik M ^a   Brouwers, Adrienne H ^a   Walenkamp, Annemiek ME ^a   Giles, Rachel H ^b   Links, Thera P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cilia; Cytoskeleton; Pancreatic cysts or serous cystadenomas; VHL tumor suppressor protein; Von Hippel Lindau disease

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ABDOMINAL PAIN; ABDOMINAL SWELLING; ALLELE; CARCINOGENESIS; CAUSAL ATTRIBUTION; CELL LOSS; CILIOPATHY; CYSTADENOMA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASES; EUKARYOTIC FLAGELLUM; FEVER; GENE; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; JAUNDICE; MOUSE MODEL; NONHUMAN; PANCREAS CYST; PRIORITY JOURNAL; PRURITUS; REVIEW; SYMPTOMATOLOGY; VHL GENE; VOMITING; VON HIPPEL LINDAU DISEASE;

EID: 84885702295     PISSN: None     EISSN: 20462530     Source Type: Journal    
DOI: 10.1186/2046-2530-2-3     Document Type: Review

References (81)

1. de Jong K, Bruno MJ, Fockens P. Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract 2012, 2012:147465. 3191780, 22007199.
2. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991, 28:443-447. 10.1136/jmg.28.7.443, 1016952, 1895313.
3. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet 2003, 361:2059-2067. 10.1016/S0140-6736(03)13643-4, 12814730.
4. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990, 77:1151-1163. 10.1093/qjmed/77.2.1151, 2274658.
5. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992, 55:898-901. 10.1136/jnnp.55.10.898, 1015185, 1431953.
6. The VHL Handbook 2012, http://www.vhl.org/patients-caregivers/resources/vhl-handbooks/, The VHL Handbook.
7. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol 2010, 221:125-138. 10.1002/path.2689, 20225241.
8. Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 2007, 142:814-818. 10.1016/j.surg.2007.09.012, 18063061.
9. Erlic Z, Ploeckinger U, Cascon A, Hoffmann MM, von Duecker L, Winter A, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, Milos I, Muresan M, Peczkowska M, Januszewicz A, Cupisti K, Tonjes A, Fasshauer M, Langrehr J, von Wussow P, Agaimy A, Schlimok G, Lamberts R, , et al. VHL-ICT Consortium, German NET Registry Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer 2010, 17:875-883. 10.1677/ERC-10-0037, 20660572, VHL-ICT Consortium, German NET Registry.
10. Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, Chauveau D, Balian A, Beigelman C, O'Toole D, Bernades P, Ruszniewski P, Richard S. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000, 119:1087-1095. 10.1053/gast.2000.18143, 11040195.
11. Horton WA, Wong V, Eldridge R. Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 1976, 136:769-777. 10.1001/archinte.1976.03630070017007, 945722.
12. Cheng TY, Su CH, Shyr YM, Lui WY. Management of pancreatic lesions in von Hippel-Lindau disease. World J Surg 1997, 21:307-312. 10.1007/s002689900234, 9015176.
13. Kanno A, Satoh K, Hamada S, Hirota M, Masamune A, Motoi F, Egawa S, Unno M, Ishida K, Kimura K, Shuin T, Shimosegawa T. Serous cystic neoplasms of the whole pancreas in a patient with von hippel-lindau disease. Intern Med 2011, 50:1293-1298. 10.2169/internalmedicine.50.4946, 21673464.
14. Hough DM, Stephens DH, Johnson CD, Binkovitz LA. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. AJR Am J Roentgenol 1994, 162:1091-1094.
15. Mukhopadhyay B, Sahdev A, Monson JP, Besser GM, Reznek RH, Chew SL. Pancreatic lesions in von Hippel-Lindau disease. Clin Endocrinol (Oxf) 2002, 57:603-608.
16. Delman KA, Shapiro SE, Jonasch EW, Lee JE, Curley SA, Evans DB, Perrier ND. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg 2006, 30:665-669. 10.1007/s00268-005-0359-4, 16617420.
17. Beerman MH, Fromkes JJ, Carey LC, Thomas FB. Pancreatic cystadenoma in von Hippel-Lindau disease: an unusual cause of pancreatic and common bile duct obstruction. J Clin Gastroenterol 1982, 4:537-540. 10.1097/00004836-198212000-00011, 7161467.
18. Jackaman FR. Polycystic pancreas: Lindau's disease. J R Coll Surg Edinb 1984, 29:121-122.
19. Deboever G, Dewulf P, Maertens J. Common bile duct obstruction due to pancreatic involvement in the von Hippel-Lindau syndrome. Am J Gastroenterol 1992, 87:1866-1868.
20. Issar SK, Kumar N, Sachdeva AK, Jain P, Puri SK. von Hippel-Lindau syndrome presenting as obstructive jaundice with involvement of pancreas in two siblings. Trop Gastroenterol 1996, 17:30-32.
21. Kunzli BM, Shrikhande SV, Buchler MW, Friess H. Pancreatic lesions in von Hippel-Lindau syndrome: report of a case. Surg Today 2004, 34:626-629.
22. Boujaoude J, Samaha E, Honein K, Noun R, Abboud B, Ghorra C, Sayegh R. A benign cause of obstructive jaundice with von Hippel-Lindau disease. A case report and review of the literature. JOP 2007, 8:790-794.
23. Gupta R, Chettri D, Sharma A, Duseja A, Dhiman RK, Chawla YK, Kalra N, Gupta A, Behera A. Pancreatic cysts causing biliary obstruction in von Hippel-Lindau syndrome. JOP 2008, 9:313-316.
24. Baek SY, Kang BC, Choi HY, Lee SW. Pancreatic serous cystadenoma associated with islet cell tumour. Br J Radiol 2000, 73:83-86.
25. Agarwal N, Kumar S, Dass J, Arora VK, Rathi V. Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature. JOP 2009, 10:55-58.
26. Charlesworth M, Verbeke CS, Falk GA, Walsh M, Smith AM, Morris-Stiff G. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg 2012, 16:1422-1428. 10.1007/s11605-012-1847-0, 22370733.
27. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994, 3:1303-1308. 10.1093/hmg/3.8.1303, 7987306.
28. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995, 5:66-75. 10.1002/humu.1380050109, 7728151.
29. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996, 8:348-357. 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3, 8956040.
30. Ritter MM, Frilling A, Crossey PA, Hoppner W, Maher ER, Mulligan L, Ponder BA, Engelhardt D. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab 1996, 81:1035-1037. 10.1210/jc.81.3.1035, 8772572.
31. Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH. Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010, 31:521-537.
32. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317-1320. 10.1126/science.8493574, 8493574.
33. Maher ER, Yates JR, Ferguson-Smith MA. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet 1990, 27:311-314. 1017082, 2352258.
34. Crossey PA, Foster K, Richards FM, Phipps ME, Latif F, Tory K, Jones MH, Bentley E, Kumar R, Lerman MI. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 1994, 93:53-58.
35. Schoenfeld A, Davidowitz EJ, Burk RD. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci U S A 1998, 95:8817-8822. 10.1073/pnas.95.15.8817, 21160, 9671762.
36. Iliopoulos O, Ohh M, Kaelin WG. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci U S A 1998, 95:11661-11666. 10.1073/pnas.95.20.11661, 21697, 9751722.
37. Haase VH. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int 2006, 69:1302-1307.
38. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ, Maher ER. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001, 10:1029-1038. 10.1093/hmg/10.10.1029, 11331613.
39. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG, Iliopoulos O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1998, 1:959-968. 10.1016/S1097-2765(00)80096-9, 9651579.
40. Kamada M, Suzuki K, Kato Y, Okuda H, Shuin T. von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility. Cancer Res 2001, 61:4184-4189.
41. Esteban-Barragan MA, Avila P, Alvarez-Tejado M, Gutierrez MD, Garcia-Pardo A, Sanchez-Madrid F, Landazuri MO. Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions. Cancer Res 2002, 62:2929-2936.
42. Grosfeld A, Stolze IP, Cockman ME, Pugh CW, Edelmann M, Kessler B, Bullock AN, Ratcliffe PJ, Masson N. Interaction of hydroxylated collagen IV with the von Hippel-Lindau tumor suppressor. J Biol Chem 2007, 282:13264-13269. 10.1074/jbc.M611648200, 17339318.
43. Kurban G, Duplan E, Ramlal N, Hudon V, Sado Y, Ninomiya Y, Pause A. Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2. Oncogene 2008, 27:1004-1012. 10.1038/sj.onc.1210709, 17700531.
44. Calzada MJ, Esteban MA, Feijoo-Cuaresma M, Castellanos MC, Naranjo-Suarez S, Temes E, Mendez F, Yanez-Mo M, Ohh M, Landazuri MO. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Res 2006, 66:1553-1560. 10.1158/0008-5472.CAN-05-3236, 16452212.
45. Kurban G, Hudon V, Duplan E, Ohh M, Pause A. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res 2006, 66:1313-1319. 10.1158/0008-5472.CAN-05-2560, 16452184.
46. Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 2003, 5:64-70. 10.1038/ncb899, 12510195.
47. Lolkema MP, Mehra N, Jorna AS, van Beest M, Giles RH, Voest EE. The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery. Exp Cell Res 2004, 301:139-146. 10.1016/j.yexcr.2004.07.016, 15530850.
48. Lolkema MP, Mans DA, Snijckers CM, van Noort M, van Beest M, Voest EE, Giles RH. The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2. FEBS Lett 2007, 581:4571-4576. 10.1016/j.febslet.2007.08.050, 17825299.
49. Mans DA, Lolkema MP, van Beest M, Daenen LG, Voest EE, Giles RH. Mobility of the von Hippel-Lindau tumour suppressor protein is regulated by kinesin-2. Exp Cell Res 2008, 314:1229-1236. 10.1016/j.yexcr.2007.12.020, 18261724.
50. Schermer B, Ghenoiu C, Bartram M, Muller RU, Kotsis F, Hohne M, Kuhn W, Rapka M, Nitschke R, Zentgraf H, Fliegauf M, Omran H, Walz G, Benzing T. The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth. J Cell Biol 2006, 175:547-554. 10.1083/jcb.200605092, 2064591, 17101696.
51. Esteban MA, Harten SK, Tran MG, Maxwell PH. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol 2006, 17:1801-1806. 10.1681/ASN.2006020181, 16775032.
52. Lutz MS, Burk RD. Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells. Cancer Res 2006, 66:6903-6907. 10.1158/0008-5472.CAN-06-0501, 16849532.
53. Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P, Hergovich A, Moch H, Meraldi P, Krek W. VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 2009, 11:994-1001. 10.1038/ncb1912, 19620968.
54. Thoma CR, Matov A, Gutbrodt KL, Hoerner CR, Smole Z, Krek W, Danuser G. Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability. J Cell Biol 2010, 190:991-1003. 10.1083/jcb.201006059, 3101603, 20855504.
55. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 1997, 151:951-956. 1858030, 9327728.
56. Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M, Scarpa A. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. Am J Pathol 2001, 158:317-321. 10.1016/S0002-9440(10)63971-5, 1850264, 11141506.
57. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI, Schulick RD, Edil BH, Choti MA, Adsay V, Klimstra DS, Offerhaus GJ, Klein AP, Kopelovich L, Carter H, Karchin R, Allen PJ, Schmidt CM, Naito Y, Diaz LA, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011, 108:21188-21193. 10.1073/pnas.1118046108, 3248495, 22158988.
58. Mohr VH, Vortmeyer AO, Zhuang Z, Libutti SK, Walther MM, Choyke PL, Zbar B, Linehan WM, Lubensky IA. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol 2000, 157:1615-1621. 10.1016/S0002-9440(10)64799-2, 1885721, 11073821.
59. Cotran RS, Kumar V, Collins T. Tissue repair: cellular growth, fibrosis and wound healing. Robbins pathologic basis of disease 1999, 89-112. WB Saunders Company, Philadelphia, Cotran RS, Kumar V, Collins T.
60. Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci 2006, 119:979-987. 10.1242/jcs.02898, 16525119.
61. Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, Mostov K. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 2007, 128:383-397. 10.1016/j.cell.2006.11.051, 1865103, 17254974.
62. Okuda H, Saitoh K, Hirai S, Iwai K, Takaki Y, Baba M, Minato N, Ohno S, Shuin T. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem 2001, 276:43611-43617. 10.1074/jbc.M107880200, 11574546.
63. Duchi S, Fagnocchi L, Cavaliere V, Hsouna A, Gargiulo G, Hsu T. Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability. Development 2010, 137:1493-1503. 10.1242/dev.042804, 2853850, 20388653.
64. Mofrad MR, Kamm RD. Introduction, with the biological basis for cell mechanics. Cytoskeletal mechanics: models and measurements 2006, 1-17. Cambridge University Press, Cambridge, Mofrad MR, Kamm RD, 1.
65. D'Angelo A, Franco B. The dynamic cilium in human diseases. Pathogenetics 2009, 2:3. 10.1186/1755-8417-2-3, 2694804, 19439065.
66. Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 2006, 131:1856-1869. 10.1053/j.gastro.2006.10.050, 17123526.
67. Pan FC, Wright C. Pancreas organogenesis: from bud to plexus to gland. Dev Dyn 2011, 240:530-565. 10.1002/dvdy.22584, 21337462.
68. Rovira M, Scott SG, Liss AS, Jensen J, Thayer SP, Leach SD. Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc Natl Acad Sci U S A 2010, 107:75-80. 10.1073/pnas.0912589107, 2806716, 20018761.
69. Lubensky IA, Pack S, Ault D, Vortmeyer AO, Libutti SK, Choyke PL, Walther MM, Linehan WM, Zhuang Z. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 1998, 153:223-231. 10.1016/S0002-9440(10)65563-0, 1852951, 9665483.
70. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klausner RD, Linehan WM. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci U S A 1997, 94:9102-9107. 10.1073/pnas.94.17.9102, 23053, 9256442.
71. Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK. Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One 2009, 4:e4897. 10.1371/journal.pone.0004897, 2660574, 19340311.
72. Zehetner J, Danzer C, Collins S, Eckhardt K, Gerber PA, Ballschmieter P, Galvanovskis J, Shimomura K, Ashcroft FM, Thorens B, Rorsman P, Krek W. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev 2008, 22:3135-3146. 10.1101/gad.496908, 2593613, 19056893.
73. Cantley J, Selman C, Shukla D, Abramov AY, Forstreuter F, Esteban MA, Claret M, Lingard SJ, Clements M, Harten SK, Asare-Anane H, Batterham RL, Herrera PL, Persaud SJ, Duchen MR, Maxwell PH, Withers DJ. Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest 2009, 119:125-135. 2613475, 19065050.
74. Puri S, Cano DA, Hebrok M. A role for von Hippel-Lindau protein in pancreatic beta-cell function. Diabetes 2009, 58:433-441. 2628617, 19033400.
75. Choi D, Cai EP, Schroer SA, Wang L, Woo M. Vhl is required for normal pancreatic beta cell function and the maintenance of beta cell mass with age in mice. Lab Invest 2011, 91:527-538. 10.1038/labinvest.2010.207, 21242957.
76. Perigny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, Sauvanet A, Belghiti J, Ruszniewski P, Bedossa P, Couvelard A. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol 2009, 33:739-748. 10.1097/PAS.0b013e3181967992, 19238077.
77. Alpert LC, Truong LD, Bossart MI, Spjut HJ. Microcystic adenoma (serous cystadenoma) of the pancreas. A study of 14 cases with immunohistochemical and electron-microscopic correlation. Am J Surg Pathol 1988, 12:251-263. 10.1097/00000478-198804000-00001, 3354751.
78. Egawa N, Maillet B, Schroder S, Mukai K, Kloppel G. Serous oligocystic and ill-demarcated adenoma of the pancreas: a variant of serous cystic adenoma. Virchows Arch 1994, 424:13-17.
79. Buisine MP, Devisme L, Degand P, Dieu MC, Gosselin B, Copin MC, Aubert JP, Porchet N. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 2000, 48:1667-1676. 10.1177/002215540004801210, 11101635.
80. Kosmahl M, Wagner J, Peters K, Sipos B, Kloppel G. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 2004, 28:339-346. 10.1097/00000478-200403000-00006, 15104296.
81. Hsu T. Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms. Oncogene 2012, 31:2247-2257. 10.1038/onc.2011.442, 3343179, 21996733.